Championing Precision Medicine In Africa and Beyond.
An impact-oriented biomedical company dedicated to ensuring better healthcare outcomes and the advancement of precision medicine (PM) in Africa (and beyond) through the discovery, development, and improved accessibility to advanced molecular diagnostics (including genomic) products and services.
Our Name and Values
Our name “Revna” is derived from the Greek word έρευνα (pronounced ehrevna) meaning research. We are therefore committed to solving clinical challenges guided by our core values:
Mission
To increase access to, the discovery of advanced molecular diagnosis in Africa as an essential step toward the enrichment of teh world's multi-omics database
Vision
To develop the smart healthcare platform and value-based solutions suite that enable better health outcomes and the advancement of precison medicine in Africa... and beyond
Doing Things Differently
We utilize a Test-Intercept/Treat (TI/T) approach that incorporates insights from our in-house advanced molecular diagnostics and clinical bioinfomatics cores for better health outcomes today and for the development of Africa's precision medicine enabling platform.
Introduction
We are an integrated biomedical company that walks the healthcare journey with patients in Sub-Saharan Africa and beyond…we:
PROVIDE ADVANCED MOLECULAR DIAGNOSTIC TESTING
We provide and enhance access to genomic and proteomic testing locally
DRIVE DISCOVERY AND DEVELOPMENT OF NOVEL SOLUTIONS
Our approach will drive the discovery and development of novel value-based solutions e.g., new diagnostics tests, treatment options etc.
ORGANIZE HEALTH CARE INFORMATION
Our multi-omics database enables organization of healthcare information into clinically actionable individualized or population-based insights.
Microbial Genomics/Infectious Diseases
In recognition of the disease burden in Sub-Saharan Africa, we are committed to utilizing our synergized approach to tackle COVID-19 and other respiratory as well endemic pathogens in the region and contribute to active disease surveillance against future threats in the region.
Oncology
By offering a comprehensive range of genomic profiling tests (germline
and somatic) as well as incorporating the latest real-world clinical evidence into test reports, we aim to ensure that the reports physicians receive provide relevant information such as tumor mutational burden, microsatellite instability status and actionable treatment options across a wide range of cancer types.
Medical Research & Applied Life Sciences
Our goal is to support the life sciences industry by facilitating biomarker identification, development and shorten the development time and distance between the discovery lab and the bedside.
Advanced Molecular Diagnostics
Advanced molecular diagnostics (proteomic and genomic testing ...
Biomarker exploration
Biomarker exploration & identification, and companion diagnostics ...
Clinical Trials
Clinical trial information & trial matching ...
Disease Monitoring
Residual disease monitoring and resistance testing ...
Drug Access Programs
Access to medicine or expanded drug access programs ...
Treatment Selection
Treatment selection and disease response monitoring and evaluation ...
Trial Management
Clinical trial management and support services e.g., tissue collection & storage, study lab testing. ...
Have a question or comment? Feel free to let us know, just fill in the information below and click the Submit button.
Stay updated! Subscribe to the ELISA weekly newsletter.